Kira Young, Ph.D.

Postdoctoral Associate

Studies hematopoiesis and the molecular basis of aging in the blood.

Visit The Trowbridge Lab

Grants, honors and accomplishments

2012 - 1st Place,Graduate Student Poster Award, NAVBO, Genetics and Genomics of Vascular Disease

2012 - Student travel award, NAVBO, Genetics and Genomics of Vascular Disease

2006-2009 - NSF-IGERT Functional Genomics Trainee

2001 - George Mitchell Peace Scholarship

1998-2003 - Pulp and Paper Scholarship

1998-2003 - Top Scholar Award

Search MagazineMarch 19, 2019
Making a difference for rural cancer patients
Dr. Jens Rueter and the Maine Cancer Genomics Initiative are providing advanced genomic tools to oncology practices throughout Maine.
Search MagazineMarch 06, 2019
From tragedy, hope and closure
Doctors who treat rare pediatric cancers face an awful truth: many of their patients will die far too young.
- Cancer/Tumors
- Cancer
Press ReleaseMarch 05, 2019
JAX receives grant to learn why flu vaccines are less effective in the elderly
$2.8 million federal grant to The Jackson Laboratory (JAX) to understand the aging-related genomic changes in immune cells that affect responses to flu vaccines.
Research HighlightFebruary 28, 2019
Fueling cancer
Cancer cells need energy. A lot of it. Their aggressive growth, not surprisingly, is therefore largely fueled by an abnormal metabolism.
- Cancer/Tumors
- Cancer

Research HighlightMarch 14, 2019
Exploring the higher risk of heart failure in aging
A recent paper from a team including JAX Professor Se-Jin Lee shows that a signaling pathway once thought to protect heart cells from damage actually promotes breakdown with aging.
Search MagazineMarch 06, 2019
Finding a better way to fight childhood cancers
Ching Lau is working to find effective therapies and test them against patients’ own tumors in specially made patient derived xenotype (PDX) mice.
Press ReleaseFebruary 28, 2019
The Jackson Laboratory signs a research agreement to identify new cancer therapeutic targets
JAX has signed a research agreement for up to $4.2 million with Sanofi to identify new targets to treat triple-negative breast cancer and ovarian carcinoma.
- Cancer/Tumors
- Cancer
Research HighlightJanuary 29, 2019
Tracing a pathway to leukemia
New research led by Jennifer Trowbridge provides insight into risk factors for clonal hematopoiesis-to-leukemia progression.
- Cancer/Tumors
- Leukemia
- Aging
- Cancer